Brainomix, a global leader and pioneer of AI-powered imaging tools in lung fibrosis and stroke, today announced it was ...

Columnist Sam Kirton explores what options are available to help IPF patients meet the costs of their medical care and medications.

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...